Skip to main content

Affiliate disclosure: We may earn a commission if you buy through links on this site — at no extra cost to you. Thanks!

HSA · FSA · HRA · Medicare

GLP-1 Providers That Accept Health Benefits Card (2026)

By WPG Research Team·Last verified: May 7, 2026·Independent comparison. Some links are affiliate links — your price doesn't change.
This guide compares providers on payment documentation signals. It is not medical, tax, or legal advice. Your clinician decides appropriateness; your benefits administrator decides eligibility.

Yes — several GLP-1 providers accept health benefits card payments. But "HSA/FSA eligible" on a marketing page does not mean your card will swipe at checkout. That gap is why you're here.

HSA or FSA card: GLP-1 medication is eligible when prescribed for obesity, type 2 diabetes, hypertension, or cardiovascular disease. MEDVi, Eden, and SkinnyRx state they accept HSA/FSA cards at checkout. SHED is sold on FSA Store and HSA Store. Hers and Ro use reimbursement-first.

Medicare Advantage flex card or OTC card: Almost certainly no. The actual Medicare path for Wegovy and Zepbound starts July 1, 2026 through CMS's Medicare GLP-1 Bridge at a $50/month copay. Section below.

HRA, LSA, or wellness card: Plan by plan. Ask your benefits team before assuming a GLP-1 program qualifies.

Best direct HSA/FSA cash-pay path

MEDVi

"HSA/FSA Approved" per provider page, listed on FSA Store + HSA Store. Compounded semaglutide from $179 first month, no membership fee.

Check Eligibility on MEDVi →

HSA/FSA approved per provider page. No membership fee on compounded plan.

Best FDA-approved + insurance navigation

Ro

$39 first month, free GLP-1 insurance coverage check. Foundayo™, Wegovy®, Zepbound®. Reimbursement-first HSA/FSA workflow.

Get Started on Ro for $39 →

Then as low as $74/month with annual plan. Free GLP-1 Insurance Coverage Checker.

Which GLP-1 Providers Accept Health Benefits Card Payments Directly?

Quick answer: We compared 8 GLP-1 telehealth providers on provider-stated HSA/FSA acceptance, FSA Store/HSA Store listings, itemized receipts, Letter of Medical Necessity availability, FDA warning letter status, and current pricing. MEDVi is the simplest cash-pay path. Eden is the strongest broad default. Ro is the strongest FDA-approved branded path with insurance navigation.

Certainty levels: Provider-stated = provider's own page. Marketplace-listed = HSA Store or FSA Store. Reimbursement-first = pay regular card, submit receipt. Card-at-checkout claims rest on provider-stated and marketplace-listed evidence — see verification section.

ProviderHSA/FSA at CheckoutFSA/HSA StoreItemized ReceiptLMN AvailableMedication PathStarting PriceBest For
MEDVi⚠ See noteProvider-statedListed (Oct 2025)YesProvider-statedCompounded semaglutide & tirzepatide; FDA-approved Wegovy & Zepbound ($99 membership path)$179 first month / $299/moCash-pay HSA/FSA, simplest checkout
EdenProvider-statedNot listedYesVerify with supportCompounded semaglutide & tirzepatide; branded options$129 first month / ~$279–349/moBroad default, no active FDA warning letter
SHEDVia FSA/HSA StoreListed (Sep 2025)YesVerify with supportOral, sublingual, injectable; brand-name cash-payVaries by formulationOral/needle-free, FSA Store buyers
SkinnyRx⚠ See noteProvider-statedNot listedYesVerify with supportCompounded semaglutide & tirzepatide (incl. oral)Varies; verify at checkoutLower price, oral tirzepatide option
Direct Meds⚠ See noteProvider-statedNot listedYesVerify with supportSublingual semaglutide, injections$249/mo sublingual / $297/mo injectableDocumentation-heavy FSA plans
HersReimbursement-firstNot listedDownloadablePlan-dependentFDA-approved Wegovy pill, Wegovy injection, Ozempic$39 first month + medication separateFemale-coded mainstream brand, Wegovy/Ozempic
RoReimbursement-firstNot listedYesPlan-dependentFDA-approved Foundayo, Zepbound, Wegovy options$39 first month, then $149/mo or $74/mo annualFDA-approved + insurance navigation
Sesame CarePer-listingNot listedYes (via support)Plan-dependentFDA-approved Wegovy, Zepbound, Ozempic, Mounjaro, Foundayo, SaxendaSubscription from $59/mo annual; medication separateBranded marketplace, provider choice, Costco members
Stated in provider documentation Mixed evidence or plan-dependent Not available
Two paths preserve the same tax savings. Swipe your HSA/FSA card directly (no paperwork) or pay with a regular card and submit a receipt for reimbursement (one extra step, identical tax outcome). The right path depends on whether you can float the cost for 2–4 weeks while reimbursement processes.

What "Health Benefits Card" Actually Means

Quick answer: "Health benefits card" is a casual umbrella term for any prepaid card tied to a tax-advantaged or employer-funded healthcare account. The five most common kinds — HSA, FSA, HRA, lifestyle spending account, and Medicare Advantage flex/OTC — work very differently for GLP-1 medications.

Look at the back of your card. The logo and the issuer tell you which kind it is.

HSA card(Health Savings Account)

Tied to a Health Savings Account — IRS only lets you open one if you have a high-deductible health plan. Money rolls over forever. You own the account. Issuers: HSA Bank, Optum Bank, HealthEquity, Fidelity, Bank of America. GLP-1 medications are eligible when prescribed for a diagnosed condition.

GLP-1 eligibility: Eligible when diagnosed condition is documented

FSA card(Flexible Spending Account)

Tied to a Flexible Spending Account through your employer. Use it or lose it by year-end (some plans allow up to a $680 carryover for 2026). The card usually says "Flex" or "Health Care." GLP-1 medications are eligible the same way as HSA. FSA administrators are sometimes stricter and ask for documentation.

GLP-1 eligibility: Eligible — same standard as HSA

HRA card(Health Reimbursement Arrangement)

Employer-funded only — you don't put money in. Rules are employer-designed and vary widely. Whether a provider that accepts HSA/FSA cards will also process your HRA card depends on your specific plan setup. Ask your benefits team.

GLP-1 eligibility: Varies by employer plan setup

LSA or wellness card(Lifestyle Spending Account)

Newer benefit type. Some employers list "weight management" as eligible; others don't. LSAs may not run through the same payment rails as HSA/FSA cards. Read your benefits handbook before assuming a GLP-1 program qualifies.

GLP-1 eligibility: Depends on employer configuration

Medicare Advantage flex/OTC card(Supplemental benefit card)

Plan-issued supplemental benefit cards from Medicare Advantage plans. Eligible uses commonly limited to OTC items, groceries, utilities, or dental/vision/hearing. Generally do not cover prescription drugs. The $50/month Medicare GLP-1 Bridge starts July 1, 2026 — see section below.

GLP-1 eligibility: Almost certainly no — see Medicare section

Why this matters

Most marketing pages say "HSA/FSA eligible" because that covers the most common cases. They don't always tell you their checkout doesn't process the same way for HRA or LSA cards, and they almost never warn Medicare flex card holders that the card won't work at all. We do.

Yes, GLP-1s Are HSA/FSA Eligible — Here's the IRS Rule

Quick answer: Under IRS guidance, prescription medications used to treat a diagnosed medical condition are qualified medical expenses. The IRS specifically lists obesity, type 2 diabetes, hypertension, and heart disease as qualifying conditions. GLP-1 medications — Wegovy, Zepbound, Ozempic, Mounjaro, Foundayo, and compounded semaglutide and tirzepatide — qualify when prescribed by a licensed provider to treat a documented condition.

The rule is simple: if a doctor prescribes a drug to treat a real medical condition, the cost is a qualified medical expense. The IRS focuses on whether the expense is medical care for a physician-diagnosed disease.

Does NOT qualify

  • Losing weight to "feel better" or "look better"
  • General wellness programs without a diagnosed condition
  • Supplements not prescribed for a specific condition

Qualifies

  • Treating obesity (BMI ≥ 30, or BMI ≥ 27 with a related condition)
  • Treating prediabetes, type 2 diabetes, or hypertension
  • Treating cardiovascular disease or heart failure
  • Treating obstructive sleep apnea (Zepbound's FDA-approved use)
  • Treating MASH liver disease (Wegovy's FDA-approved use)
Why a Letter of Medical Necessity matters: A one-page note from your prescriber tying the medication to your diagnosis gives you the strongest documentation package available. Even with rock-solid IRS eligibility, your specific plan administrator can still flag a charge for documentation — an itemized receipt plus an LMN clears it.
The provider you should avoid for documentation-sensitive plans: Yucca Health's own FAQ states they do not provide itemized receipts or letters of medical necessity — making them a poor fit for anyone whose plan has ever asked for documentation.

The 8 Providers Ranked: Best Fit by Card Type and Buyer Profile

Ranked by which checkout works, which paperwork is provided, and which medication type the searcher actually wants. We name names where it matters.

#1 Best direct HSA/FSA cash-pay pathFDA warning letter

MEDVi

Check Eligibility on MEDVi →
Quick answer: MEDVi states on its own page that HSA and FSA cards are accepted ("HSA/FSA Approved"), and the provider is listed on both FSA Store and HSA Store via the Health-E Commerce partnership announced October 2025. Compounded semaglutide starts at $179 the first month and $299/month ongoing, with no membership fee on the compounded path.

Among the providers we compared, MEDVi is one of the cleanest HSA/FSA experiences in the GLP-1 space. Their public landing page carries an "HSA/FSA Approved" badge. The FSA Store and HSA Store listings (added October 2025 via Health-E Commerce) put MEDVi on the same merchant infrastructure as established medical retailers — which is the kind of merchant code most plan administrators recognize.

Two separate paths on the same platform: a compounded GLP-1 program (semaglutide and tirzepatide injections, compounded GLP-1 tablets) at flat cash-pay pricing with no membership fee, and a separate FDA-approved branded path (Wegovy® pill, Wegovy® injection, Zepbound® injection) at "$99 Membership + Medication." For most cash-pay HSA/FSA shoppers on this page, the compounded path is the simpler, lower-friction option.

Disclosed plainly: On February 20, 2026, the FDA issued MEDVi Warning Letter #721455 over false or misleading representations involving compounded semaglutide and tirzepatide marketing — including claims implying FDA approval or evaluation. This was a marketing-and-labeling issue, not a recall. MEDVi remains operational, prescriptions are still filled by licensed compounding pharmacies.
MEDVi is NOT the right fit if: You specifically want FDA-approved branded medication with prior-authorization help (Ro is the better path). Your plan administrator is unusually strict and you'd rather avoid any provider with a current FDA warning letter (Eden has a clean regulatory record). You prefer oral or sublingual specifically (SHED is the specialist).
#2 Best broad default, no active FDA warning letter

Eden

Check Eligibility on Eden →
Quick answer: Eden's payment FAQ states you can use an HSA or FSA card for most visits and prescriptions. Flat pricing across all doses, no membership fee, and access to both compounded and select branded GLP-1 options. Compounded semaglutide starts at $129 the first month on a 3-month plan; compounded tirzepatide starts at $249 the first month. No active FDA warning letter at time of verification.

Eden's marketing line is "No insurance required. FSA/HSA eligible. 100% online. Free shipping." Their FAQ backs that up. The flat-pricing structure means your monthly cost stays the same whether you're on a 0.25 mg starter dose or a 2.4 mg maintenance dose — that alone can save hundreds over a six-month course versus dose-tiered competitors.

Eden advantages for this search

  • Clean regulatory record (no active FDA warning letter)
  • HSA/FSA accepted per provider FAQ
  • Flat pricing across all doses
  • No membership fee
  • Both compounded and branded lanes

Honest caveats

  • $129 first-month price tied to a 3-month plan
  • LMN availability — verify with support
Not the right fit if: You need strict month-to-month flexibility (MEDVi compounded path is closer) or you specifically want needle-free oral/sublingual (SHED).
#3 Best for oral, sublingual, and needle-averse buyers

SHED

Check SHED's GLP-1 Programs →
Quick answer: SHED is one of the few GLP-1 providers explicitly listed on both FSA Store and HSA Store via the Health-E Commerce partnership announced September 2025. Specializes in compounded oral and sublingual semaglutide for buyers who don't want to inject. Also offers brand-name Wegovy and Zepbound on a separate cash-pay plan.

SHED built their platform around oral and sublingual options — drops you take under your tongue, tablets you swallow. For someone who's needle-averse or has needle phobia, that's a meaningful differentiator. The Health-E Commerce partnership put SHED on FSA Store and HSA Store — a useful eligibility signal, though plan administrators can still ask for substantiation on bundled coaching or supplements.

Important on terms: FSA Store's SHED listing states all programs require a two-month commitment, monthly subscriptions can be canceled after two months, and payments are non-refundable. Verify exact pricing for your chosen formulation at checkout.
Not the right fit if: You prefer injections (most clinical data is on injectable forms — discuss with your prescriber) or you need strict month-to-month with no minimum commitment.
#4 Best FDA-approved branded path with insurance concierge

Ro

Get Started on Ro for $39 →
Quick answer: Ro is the strongest path for FDA-approved branded GLP-1s with full insurance navigation. Ro doesn't accept HSA/FSA cards directly at checkout, but the insurance concierge handles prior authorization at no extra cost and produces clean itemized receipts you can submit to your HSA/FSA administrator for reimbursement. Get started for $39, then $149/month or as low as $74/month with annual plan paid upfront. Medication billed separately.

If your insurance might cover Wegovy or Zepbound, the math usually favors Ro. Most patients can't navigate prior authorization on their own — insurance companies auto-deny incomplete submissions. Ro's concierge team handles that paperwork daily. Ro also runs a free GLP-1 Insurance Coverage Checker so you can see whether your plan covers branded GLP-1 before you sign up.

The HSA/FSA workflow at Ro

Ro's FAQ states they do not currently accept HSA/FSA cards at checkout. You pay Ro with a regular credit card. Ro provides an itemized receipt. You submit the receipt to your HSA/FSA administrator for reimbursement. Same tax advantage, one extra step.

Ro carries: Foundayo™ (orforglipron — FDA-approved oral GLP-1 from Eli Lilly), Zepbound® (tirzepatide), Wegovy® injection and pill, and additional FDA-approved options. Verify current formulary at sign-up.

Not the right fit if: You specifically want direct HSA/FSA card swipe at checkout (go to MEDVi) or you don't have any health insurance and want the cheapest cash-pay path (go to Eden).
#5 Lower price point with direct card acceptanceFDA warning letter

SkinnyRx

Check SkinnyRx Eligibility →

SkinnyRx's FAQ confirms HSA/FSA card acceptance, with product pages displaying "FSA/HSA eligible" badges. Direct card at checkout per their FAQ, and they're one of the only providers offering oral tirzepatide as a publicly listed option.

Disclosure: SkinnyRx received FDA Warning Letter MARCS-CMS 717989 on February 20, 2026 over compounded GLP-1 marketing claims. Like MEDVi's, this was a marketing-language issue, not a recall. They remain operational. Disclosed for full transparency.
#6 Best for documentation-heavy FSA plansFDA warning letter

Direct Meds

Check Direct Meds Pricing

Direct Meds publicly states they accept HSA/FSA for all GLP-1 treatments and provide receipts and documentation for reimbursement. Their public language emphasizes the documentation packet — exactly what strict plan administrators want. Sublingual semaglutide starts at $249/month; injections start at $297/month.

Disclosure: Direct Meds received FDA Warning Letter MARCS-CMS 716822 on September 9, 2025 for false or misleading claims about compounded semaglutide and tirzepatide. This was a marketing-language issue, not a recall. They remain operational. Disclosed for full transparency.
#7 FDA-approved Wegovy and Ozempic via reimbursement-first path

Hers / Hims

Following the March 2026 Novo Nordisk partnership, Hers offers FDA-approved Wegovy® pill, Wegovy® injection, and Ozempic. Hims mirrors Hers for male-coded buyers. Membership starts at $39 first month and $149/month ongoing; medication is billed separately.

Hers tells you upfront on their HSA/FSA page that "payment with FSA/HSA card may require additional steps from your provider" — them being transparent that direct card processing is unreliable, and reimbursement is the cleaner path. Their itemized receipts are downloadable from the app and easy to submit.

Not the right fit if: Direct HSA/FSA card swipe at checkout is your top priority (go to MEDVi or Eden).

#8 Branded marketplace with provider choice

Sesame Care

Browse GLP-1 Providers on Sesame →

Sesame Care is a per-clinician marketplace offering Wegovy®, Zepbound®, Ozempic®, Mounjaro®, Foundayo®, and Saxenda® across multiple providers. Sesame's page states most subscription services may be eligible for HSA/FSA reimbursement, and support can provide an itemized bill. Success by Sesame ongoing care starts as low as $59/month with annual subscription; cash-pay GLP-1 medications start as low as $149/month for Wegovy pill and Foundayo.

Best for: Maximum branded medication breadth, buyers who want to choose between multiple clinicians, and Costco members (Sesame has run Costco-member pricing on Wegovy and Ozempic).

Why Your Health Benefits Card Got Declined (And How to Stop It Next Time)

Quick answer: A health benefits card can decline even when the expense is fully eligible. The most common reasons are: merchant category code mismatch, provider doesn't accept the card directly, plan requires substantiation first, insufficient funds, or compounded medication flagged. None of these mean your prescription isn't eligible — they mean the operational path failed.
If your card just got rejected: take a breath. This is fixable in most cases. A declined card today doesn't mean you can't use your HSA/FSA dollars for this prescription — it means the direct-card-at-checkout path failed, and you need to use the reimbursement path instead. Your tax savings are identical either way.
1

The merchant category code (MCC) doesn't match

Every credit card transaction carries a 4-digit code that tells the card network what kind of business is processing the charge. Your HSA/FSA card is set up to accept charges from medical-related codes. Some telehealth providers process under a code your plan flags as "subscription" or "wellness" instead of "pharmacy" or "medical." The fix: pay with a regular card and submit the receipt for reimbursement.

2

The provider doesn't accept HSA/FSA cards directly at checkout

Hers and Ro both fall in this bucket — they explicitly use a reimbursement-first model. If you put your HSA/FSA card in their checkout, it may process as a regular card charge and your tax advantage only kicks in when you submit the receipt later.

3

Your plan requires substantiation

Many HSA/FSA plans use IIAS — the Inventory Information Approval System — which auto-approves charges from merchants on a pre-approved list. If the provider isn't on the list, the charge can process but your plan emails you asking to upload documentation. Upload the itemized receipt and (if asked) the Letter of Medical Necessity. Done.

4

Insufficient funds

Especially true for HRAs, which sometimes release funds quarterly rather than all at once. Check your benefits portal balance before you check out.

5

Compounded medication flagged

Some FSA administrators auto-flag compounded prescriptions because the NDC (National Drug Code) doesn't match a standard pharmacy database. Solution: have an LMN ready from day one. Ask your prescriber at the first telehealth visit.

The Pre-Purchase Script

Quick answer: Before you enter your health benefits card, run a 60-second check: confirm your card type, confirm available balance, confirm the provider's checkout policy, get your prescription documented, request a Letter of Medical Necessity, and save the itemized receipt immediately after purchase. This prevents the three most common failure modes: declined transaction, denied reimbursement, and audit flag.

What to ask the provider (paste into their support chat or call)

"I'm planning to use my HSA/FSA card for a GLP-1 prescription. Three quick questions: (1) Do you accept HSA or FSA debit cards directly at checkout? (2) If the card declines or my plan asks for documentation, do you provide an itemized receipt and a Letter of Medical Necessity? (3) Are there any membership or program fees that aren't reimbursable, separate from the medication cost?"

What to ask your benefits administrator (call the number on the back of your card)

"My doctor may prescribe a GLP-1 medication for a diagnosed medical condition. What documentation do you require for reimbursement? Do you treat compounded medications differently from brand-name? Do you treat telehealth program fees differently from medication costs?"

Before you click "place order," screenshot these

  • The provider's HSA/FSA statement or eligibility page
  • Your shopping cart with the medication and price visible
  • The terms of service and cancellation policy
  • Any "FSA/HSA eligible" badges on the product page

After you place the order

  • Download the itemized receipt immediately — some providers email it once and never resend
  • Save it to a folder labeled "[Year] Health Expenses"
  • If you needed an LMN, save that PDF in the same folder

Can I Use a Medicare Advantage Flex Card for GLP-1 Medication?

Quick answer: Almost always no. Medicare Advantage flex cards and OTC cards are plan-issued supplemental benefit cards — not standard Medicare drug coverage — and eligible uses are commonly limited to OTC items, groceries, utilities, or dental/vision/hearing. The actual Medicare path for GLP-1s for weight loss is the Medicare GLP-1 Bridge — a CMS short-term demonstration starting July 1, 2026 that provides eligible Medicare Part D beneficiaries with Wegovy, Zepbound, and Foundayo at a $50/month copay.

If you're a Medicare beneficiary who landed on this page hoping your flex card would pay for Wegovy: it almost certainly won't. But there's better news right behind it.

What a Medicare flex card actually is

It's a supplemental allowance some Medicare Advantage plans offer (Humana, UnitedHealthcare, Aetna, Wellcare, and others). The card is a prepaid debit card restricted by plan to specific categories — OTC items, sometimes groceries for members with chronic conditions, utility bills, or supplemental dental/vision/hearing benefits. It is generally not valid for prescription drugs. The misleading TV ads suggesting "$2,800 added to your card" are exactly that — misleading.

Why Medicare Part D historically hasn't covered GLP-1s for weight loss

The Medicare Prescription Drug, Improvement, and Modernization Act of 2003 specifically excluded drugs used for weight loss from Part D coverage. Part D plans can cover GLP-1s for type 2 diabetes (Ozempic, Mounjaro), cardiovascular risk reduction (Wegovy), or sleep apnea (Zepbound) — but not for weight loss alone.

The actual Medicare path: the Medicare GLP-1 Bridge

Starting July 1, 2026 through December 31, 2027, CMS is running a short-term demonstration program providing eligible Medicare Part D beneficiaries with covered GLP-1 medications at a flat $50/month copay. CMS uses a central processor (run by Humana, the LI NET program administrator).

Included medications

Foundayo® (orforglipron), Wegovy® injection and tablets, Zepbound® KwikPen. Note: single-dose vial and single-dose pen formulations of Zepbound are not in the program.

Who qualifies

  • Enrolled in Medicare Part D (standalone PDP or Medicare Advantage with drug coverage)
  • BMI of 35 or higher (no other condition required), OR
  • BMI of 30+ with heart failure, uncontrolled hypertension, or stage 3a+ chronic kidney disease, OR
  • BMI of 27+ with prediabetes, prior heart attack, prior stroke, or symptomatic peripheral artery disease
The catches: The $50 doesn't count toward your Part D TrOOP costs or the $2,100 annual out-of-pocket cap. You can't combine the Bridge copay with the Part D Low-Income Subsidy or with manufacturer coupons. The Bridge ends December 31, 2027.

What if you have an existing HSA from before Medicare?

You can still use those existing HSA funds tax-free for qualified medical expenses, including a self-pay GLP-1 from MEDVi, Eden, SHED, or any provider in our comparison table. Per IRS Publication 969, your HSA contribution limit drops to zero starting the first month you're enrolled in Medicare — but the money already in your account stays yours. That's the bridge before the Bridge.

Are Compounded GLP-1 Medications HSA/FSA Eligible?

Quick answer: Both brand-name and compounded GLP-1 expenses can be reimbursable through HSA, FSA, or HRA when they qualify as medical care for a diagnosed condition. That does not make compounded drugs FDA-approved. The FDA has explicitly stated that compounded drugs are not FDA-approved, and recent FDA enforcement has targeted compounded GLP-1 marketing that implies FDA approval.

FDA-approved GLP-1 medications

  • Wegovy (semaglutide, chronic weight management)
  • Zepbound (tirzepatide, chronic weight management)
  • Saxenda (liraglutide, chronic weight management)
  • Foundayo (orforglipron — FDA-approved April 1, 2026)
  • Ozempic / Mounjaro: FDA-approved for T2D, may be prescribed off-label for weight loss

Recognized instantly by insurance and HSA/FSA administrators via standard NDC.

Compounded GLP-1 medications

  • Prepared by licensed compounding pharmacies under a doctor's prescription
  • Not FDA-approved
  • Not generic equivalents to brand-name medications
  • HSA/FSA eligible when prescribed for a diagnosed condition — but may require extra documentation
  • Some FSA administrators flag compounded charges for substantiation

Have an LMN from day one to avoid substantiation friction.

For HSA/FSA purposes, the IRS focuses on whether the expense is qualified medical care for a physician-diagnosed disease. Both brand-name and compounded GLP-1 prescriptions can meet that standard. Plan administrators may apply additional substantiation rules, and compounded status sometimes creates documentation friction. The fix is the same: have an LMN from day one.

How Much Can You Actually Save with Your Health Benefits Card?

Quick answer: The savings come from using pre-tax dollars, not from a discount on the medication. At a 25% combined tax rate, paying $299/month for a GLP-1 program with HSA/FSA dollars saves about $897 over 12 months versus paying with after-tax money.
Provider Example (Compounded)Monthly Cost6-Month Total12-Month TotalEst. Tax Savings (25%)Effective 12-Mo Cost
MEDVi semaglutide ($179 first month, $299 refills)$299 ongoing$1,674$3,468$867$2,601
SkinnyRx semaglutide (varies in checkout)$299 (assumed)$1,794$3,588$897$2,691
Eden compounded ongoing$329$1,974$3,948$987$2,961
Direct Meds sublingual semaglutide$249$1,494$2,988$747$2,241
Direct Meds injectable semaglutide$297$1,782$3,564$891$2,673

Estimates only — not tax advice. Actual savings depend on your federal bracket, state bracket, FICA rate, and whether the expense is approved by your specific plan administrator.

2026 contribution limits

  • HSA self-only$4,400
  • HSA family$8,750
  • Health FSA maximum$3,400
  • FSA carryover maximum (2026)$680

Per IRS Revenue Procedure 2025-19. Verify your plan's carryover allowance.

The triple-tax-free play

If you have an HSA and can afford to pay GLP-1 costs out of pocket, do that. Save your receipts. Let the HSA money grow tax-free in your investment account for years. Then reimburse yourself for those receipts whenever you want — the IRS allows reimbursement at any point after the HSA was established.

How We Verified This

Provider-direct sources checked

MEDVi GLP-1 landing page, Eden weight loss FAQ, SHED page and FSA Store SHED listing, SkinnyRx FAQ, Direct Meds product pages, Hers HSA/FSA page, Hims HSA/FSA page, Ro membership page and FAQ, Sesame Care weight loss program page, Yucca Health FAQ.

Marketplace sources

Health-E Commerce / SHED partnership press release (September 2025), Health-E Commerce / MEDVi partnership listing (October 2025), HSA Store and FSA Store provider directories.

Regulatory sources

IRS guidance on weight-loss program eligibility; IRS Revenue Procedure 2025-19 (2026 HSA limits); IRS Publication 969 (HSA rules including Medicare interaction); CMS Medicare GLP-1 Bridge program page; FDA Warning Letter database — MEDVi #721455 (February 20, 2026), SkinnyRx #717989 (February 20, 2026), Direct Meds #716822 (September 9, 2025); FDA statements on compounded GLP-1 marketing and supply. FDA approval of Foundayo (orforglipron) April 1, 2026.

What we did not do

We did not stage transactions to verify every checkout in real time across every plan administrator. Real-card processing depends on your specific HSA/FSA card issuer, the merchant category code each provider's processor uses, and your plan administrator's substantiation rules. We've labeled that uncertainty honestly throughout.

Re-verification cadence

Monthly for provider pricing and HSA/FSA policy. Quarterly for FSA Store / HSA Store listings. Immediately after any FDA action.

Frequently Asked Questions

Yes. When Wegovy is prescribed for a diagnosed medical condition — obesity, overweight with a related condition, cardiovascular disease, or MASH liver disease — it is a qualified medical expense. Whether the card processes at checkout depends on the merchant. Ro is reimbursement-first, while a retail pharmacy filling a Wegovy prescription will typically process the card directly.

Yes, when prescribed by a licensed provider for a diagnosed condition. Some FSA plans flag compounded charges and request a Letter of Medical Necessity. Ask your prescriber for an LMN at your first telehealth visit.

Almost always no. Medicare flex cards are plan-issued supplemental cards usually limited to OTC items, groceries, utilities, or dental/vision/hearing — not prescription drugs. The actual Medicare path for GLP-1s for weight loss is the Medicare GLP-1 Bridge starting July 1, 2026 — $50/month copay for eligible Part D beneficiaries who meet BMI and clinical criteria.

Not always, but it prevents problems. Some plan administrators auto-approve prescription drug charges; others ask for documentation. Getting an LMN at your first telehealth consultation gives you what you need if your administrator asks for one later.

As of May 2026, MEDVi, Eden, SkinnyRx, and Direct Meds state on their own pages that they accept HSA/FSA cards at checkout. SHED is listed on both FSA Store and HSA Store via the Health-E Commerce partnership. Hers and Ro use a reimbursement-first model.

The most common reason is the merchant category code (MCC). HSA cards are configured to accept charges from medical-related codes. Some telehealth providers process charges under "subscription" or "wellness" codes that your plan flags, even when the underlying expense is fully eligible. The fix: pay with a regular card and submit the receipt for reimbursement.

"Eligible" means the expense qualifies as a qualified medical expense — the tax advantage applies regardless of how you pay. "Accepted at checkout" means the provider's payment processor recognizes your HSA/FSA card and processes the charge directly. Eligible-but-not-accepted-at-checkout providers still preserve your tax advantage through reimbursement.

You can use existing HSA funds tax-free for qualified medical expenses including GLP-1s. Per IRS Publication 969, your HSA contribution limit drops to zero starting the first month you're enrolled in Medicare. The Medicare GLP-1 Bridge (starting July 1, 2026) is the new $50/month path for eligible Part D beneficiaries.

These are HSA/FSA administrators and card issuers — not different card types. Whether your card processes depends on the merchant, the card network, the merchant category code, and your plan's substantiation rules. The provider matters more than the issuer.

Most FSAs are use-it-or-lose-it. Some plans allow up to a $680 carryover for 2026 (verify your plan's current limit) or a short grace period. HSAs roll over indefinitely. If you have FSA money expiring, MEDVi, Eden, SHED, and SkinnyRx all state HSA/FSA card acceptance so you don't have to wait for reimbursement.

HRA card use is employer-plan-specific. Don't assume a provider that accepts HSA/FSA cards will process an HRA card at checkout — confirm with the provider or your benefits administrator before purchase.

LSA/wellness cards are employer-specific and may not run through the same payment rails as HSA/FSA cards. Read your benefits handbook before assuming a GLP-1 program qualifies.

Still Not Sure Which GLP-1 Program Is Right for You?

Take our free 60-second matching quiz. We'll factor in your card type (HSA, FSA, HRA, LSA, Medicare), insurance status, medication preference, and budget — and route you to the provider that fits.

Three questions. No email required. No pressure.

Take the Free 60-Second GLP-1 Matching Quiz →

Verified May 7, 2026. Provider policies, prices, FDA status, and Medicare program details change. We re-verify monthly. If something on this page contradicts a provider's current site, the provider's site is more current.

Weight Loss Provider Guide is an independent comparison resource for GLP-1 telehealth providers. We earn affiliate commissions when readers connect with providers we recommend; this never changes our editorial conclusions.

This page is for general informational purposes and does not constitute medical, tax, or legal advice. GLP-1 medications are prescription treatments that require evaluation by a licensed clinician. Consult your healthcare provider and your tax advisor or benefits administrator before making decisions based on this content.